Global Hepatitis B Human Immunoglobulin Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 49035
  • calendar_today Published On: Mar, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Hepatitis B Human Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Hepatitis B Human Immunoglobulin size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Hepatitis B Human Immunoglobulin market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Hepatitis B Human Immunoglobulin market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

100IU

200IU

400IU

Market segment by Application can be divided into

Measles Prevention

Prevention of Hepatitis B Virus Infection

Hepatitis A Virus Infection

Other

The key market players for global Hepatitis B Human Immunoglobulin market are listed below:

Biotest

ADMA Biologics

Sanquin Blood

Bio Products Laboratory

Baxter

CSL

Bayer

Grifols

Octapharma

Hualan Biological

China Biologic

Tiantan Biologic

Shuanglin Bio-pharmacy

Sichuan Yuanda Shuyang

Shanghai Institute of Biological

Hualan

Shanghai RAAS Blood Products

China Grand Enterprises

Nanyue Biopharmaceutical

Boya Biopharmaceutical Group

Tonglu Biopharmaceutical

Shandong Taibang Biopharmaceutical

Guangdong Shuanglin Biopharmaceutical

Chengdu Rongsheng Pharmaceutical

Shenzhen Weiguang Biopharmaceutical

Green Cross (China) Biological Products

Sinopharm

Market segment by Region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:

Chapter 1, to describe Hepatitis B Human Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Hepatitis B Human Immunoglobulin, with price, sales, revenue and global market share of Hepatitis B Human Immunoglobulin in 2018 and 2019.

Chapter 3, the Hepatitis B Human Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Hepatitis B Human Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.

Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Hepatitis B Human Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.

Chapter 12, 13 and 14, to describe Hepatitis B Human Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Hepatitis B Human Immunoglobulin Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Hepatitis B Human Immunoglobulin Revenue by Type: 2019 Versus 2021 Versus 2026

1.2.2 100IU

1.2.3 200IU

1.2.4 400IU

1.3 Market Analysis by Application

1.3.1 Overview: Global Hepatitis B Human Immunoglobulin Revenue by Application: 2019 Versus 2021 Versus 2026

1.3.2 Measles Prevention

1.3.3 Prevention of Hepatitis B Virus Infection

1.3.4 Hepatitis A Virus Infection

1.3.5 Other

1.4 Global Hepatitis B Human Immunoglobulin Market Size & Forecast

1.4.1 Global Hepatitis B Human Immunoglobulin Sales in Value (2016-2026))

1.4.2 Global Hepatitis B Human Immunoglobulin Sales in Volume (2016-2026)

1.4.3 Global Hepatitis B Human Immunoglobulin Price by Type (2016-2026) & (US$/ML)

1.5 Global Hepatitis B Human Immunoglobulin Production Capacity Analysis

1.5.1 Global Hepatitis B Human Immunoglobulin Total Production Capacity (2016-2026)

1.5.2 Global Hepatitis B Human Immunoglobulin Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Hepatitis B Human Immunoglobulin Market Drivers

1.6.2 Hepatitis B Human Immunoglobulin Market Restraints

1.6.3 Hepatitis B Human Immunoglobulin Trends Analysis

2 Manufacturers Profiles

2.1 Biotest

2.1.1 Biotest Details

2.1.2 Biotest Major Business

2.1.3 Biotest Hepatitis B Human Immunoglobulin Product and Services

2.1.4 Biotest Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.2 ADMA Biologics

2.2.1 ADMA Biologics Details

2.2.2 ADMA Biologics Major Business

2.2.3 ADMA Biologics Hepatitis B Human Immunoglobulin Product and Services

2.2.4 ADMA Biologics Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.3 Sanquin Blood

2.3.1 Sanquin Blood Details

2.3.2 Sanquin Blood Major Business

2.3.3 Sanquin Blood Hepatitis B Human Immunoglobulin Product and Services

2.3.4 Sanquin Blood Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.4 Bio Products Laboratory

2.4.1 Bio Products Laboratory Details

2.4.2 Bio Products Laboratory Major Business

2.4.3 Bio Products Laboratory Hepatitis B Human Immunoglobulin Product and Services

2.4.4 Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.5 Baxter

2.5.1 Baxter Details

2.5.2 Baxter Major Business

2.5.3 Baxter Hepatitis B Human Immunoglobulin Product and Services

2.5.4 Baxter Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.6 CSL

2.6.1 CSL Details

2.6.2 CSL Major Business

2.6.3 CSL Hepatitis B Human Immunoglobulin Product and Services

2.6.4 CSL Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.7 Bayer

2.7.1 Bayer Details

2.7.2 Bayer Major Business

2.7.3 Bayer Hepatitis B Human Immunoglobulin Product and Services

2.7.4 Bayer Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.8 Grifols

2.8.1 Grifols Details

2.8.2 Grifols Major Business

2.8.3 Grifols Hepatitis B Human Immunoglobulin Product and Services

2.8.4 Grifols Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.9 Octapharma

2.9.1 Octapharma Details

2.9.2 Octapharma Major Business

2.9.3 Octapharma Hepatitis B Human Immunoglobulin Product and Services

2.9.4 Octapharma Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.10 Hualan Biological

2.10.1 Hualan Biological Details

2.10.2 Hualan Biological Major Business

2.10.3 Hualan Biological Hepatitis B Human Immunoglobulin Product and Services

2.10.4 Hualan Biological Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.11 China Biologic

2.11.1 China Biologic Details

2.11.2 China Biologic Major Business

2.11.3 China Biologic Hepatitis B Human Immunoglobulin Product and Services

2.11.4 China Biologic Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.12 Tiantan Biologic

2.12.1 Tiantan Biologic Details

2.12.2 Tiantan Biologic Major Business

2.12.3 Tiantan Biologic Hepatitis B Human Immunoglobulin Product and Services

2.12.4 Tiantan Biologic Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.13 Shuanglin Bio-pharmacy

2.13.1 Shuanglin Bio-pharmacy Details

2.13.2 Shuanglin Bio-pharmacy Major Business

2.13.3 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product and Services

2.13.4 Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.14 Sichuan Yuanda Shuyang

2.14.1 Sichuan Yuanda Shuyang Details

2.14.2 Sichuan Yuanda Shuyang Major Business

2.14.3 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product and Services

2.14.4 Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.15 Shanghai Institute of Biological

2.15.1 Shanghai Institute of Biological Details

2.15.2 Shanghai Institute of Biological Major Business

2.15.3 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product and Services

2.15.4 Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.16 Hualan

2.16.1 Hualan Details

2.16.2 Hualan Major Business

2.16.3 Hualan Hepatitis B Human Immunoglobulin Product and Services

2.16.4 Hualan Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.17 Shanghai RAAS Blood Products

2.17.1 Shanghai RAAS Blood Products Details

2.17.2 Shanghai RAAS Blood Products Major Business

2.17.3 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product and Services

2.17.4 Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.18 China Grand Enterprises

2.18.1 China Grand Enterprises Details

2.18.2 China Grand Enterprises Major Business

2.18.3 China Grand Enterprises Hepatitis B Human Immunoglobulin Product and Services

2.18.4 China Grand Enterprises Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.19 Nanyue Biopharmaceutical

2.19.1 Nanyue Biopharmaceutical Details

2.19.2 Nanyue Biopharmaceutical Major Business

2.19.3 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.19.4 Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.20 Boya Biopharmaceutical Group

2.20.1 Boya Biopharmaceutical Group Details

2.20.2 Boya Biopharmaceutical Group Major Business

2.20.3 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product and Services

2.20.4 Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.21 Tonglu Biopharmaceutical

2.21.1 Tonglu Biopharmaceutical Details

2.21.2 Tonglu Biopharmaceutical Major Business

2.21.3 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.21.4 Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.22 Shandong Taibang Biopharmaceutical

2.22.1 Shandong Taibang Biopharmaceutical Details

2.22.2 Shandong Taibang Biopharmaceutical Major Business

2.22.3 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.22.4 Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.23 Guangdong Shuanglin Biopharmaceutical

2.23.1 Guangdong Shuanglin Biopharmaceutical Details

2.23.2 Guangdong Shuanglin Biopharmaceutical Major Business

2.23.3 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.23.4 Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.24 Chengdu Rongsheng Pharmaceutical

2.24.1 Chengdu Rongsheng Pharmaceutical Details

2.24.2 Chengdu Rongsheng Pharmaceutical Major Business

2.24.3 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.24.4 Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.25 Shenzhen Weiguang Biopharmaceutical

2.25.1 Shenzhen Weiguang Biopharmaceutical Details

2.25.2 Shenzhen Weiguang Biopharmaceutical Major Business

2.25.3 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

2.25.4 Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.26 Green Cross (China) Biological Products

2.26.1 Green Cross (China) Biological Products Details

2.26.2 Green Cross (China) Biological Products Major Business

2.26.3 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product and Services

2.26.4 Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

2.27 Sinopharm

2.27.1 Sinopharm Details

2.27.2 Sinopharm Major Business

2.27.3 Sinopharm Hepatitis B Human Immunoglobulin Product and Services

2.27.4 Sinopharm Hepatitis B Human Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)

3 Hepatitis B Human Immunoglobulin Sales by Manufacturer

3.1 Global Hepatitis B Human Immunoglobulin Sales in Volume by Manufacturer (2019-2021e)

3.2 Global Hepatitis B Human Immunoglobulin Revenue by Manufacturer (2019-2021e)

3.3 Key Manufacturer Market Position in Hepatitis B Human Immunoglobulin

3.4 Market Concentration Rate

3.4.1 Top 3 Hepatitis B Human Immunoglobulin Manufacturer Market Share

3.4.2 Top 6 Hepatitis B Human Immunoglobulin Manufacturer Market Share

3.5 Global Hepatitis B Human Immunoglobulin Production Capacity by Company

3.6 Manufacturer by Geography: Head Office and Hepatitis B Human Immunoglobulin Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Hepatitis B Human Immunoglobulin Market Size by Region

4.1.1 Global Hepatitis B Human Immunoglobulin Sales in Volume by Region (2016-2026)

4.1.2 Global Hepatitis B Human Immunoglobulin Revenue by Region (2016-2026)

4.2 North America Hepatitis B Human Immunoglobulin Revenue (2016-2026)

4.3 Europe Hepatitis B Human Immunoglobulin Revenue (2016-2026)

4.4 Asia-Pacific Hepatitis B Human Immunoglobulin Revenue (2016-2026)

4.5 South America Hepatitis B Human Immunoglobulin Revenue (2016-2026)

4.6 Middle East and Africa Hepatitis B Human Immunoglobulin Revenue (2016-2026)

5 Market Segment by Type

5.1 Global Hepatitis B Human Immunoglobulin Sales in Volume by Type (2016-2026)

5.2 Global Hepatitis B Human Immunoglobulin Revenue by Type (2016-2026)

5.3 Global Hepatitis B Human Immunoglobulin Price by Type (2016-2026)

6 Market Segment by Application

6.1 Global Hepatitis B Human Immunoglobulin Sales in Volume by Application (2016-2026)

6.2 Global Hepatitis B Human Immunoglobulin Revenue by Application (2016-2026)

6.3 Global Hepatitis B Human Immunoglobulin Price by Application (2016-2026)

7 North America by Country, by Type, and by Application

7.1 North America Hepatitis B Human Immunoglobulin Sales by Type (2016-2026)

7.2 North America Hepatitis B Human Immunoglobulin Sales by Application (2016-2026)

7.3 North America Hepatitis B Human Immunoglobulin Market Size by Country

7.3.1 North America Hepatitis B Human Immunoglobulin Sales in Volume by Country (2016-2026)

7.3.2 North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2026)

7.3.3 United States Market Size and Forecast (2016-2026)

7.3.4 Canada Market Size and Forecast (2016-2026)

7.3.5 Mexico Market Size and Forecast (2016-2026)

8 Europe by Country, by Type, and by Application

8.1 Europe Hepatitis B Human Immunoglobulin Sales by Type (2016-2026)

8.2 Europe Hepatitis B Human Immunoglobulin Sales by Application (2016-2026)

8.3 Europe Hepatitis B Human Immunoglobulin Market Size by Country

8.3.1 Europe Hepatitis B Human Immunoglobulin Sales in Volume by Country (2016-2026)

8.3.2 Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2026)

8.3.3 Germany Market Size and Forecast (2016-2026)

8.3.4 France Market Size and Forecast (2016-2026)

8.3.5 United Kingdom Market Size and Forecast (2016-2026)

8.3.6 Russia Market Size and Forecast (2016-2026)

8.3.7 Italy Market Size and Forecast (2016-2026)

9 Asia-Pacific by Country, by Type, and by Application

9.1 Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Type (2016-2026)

9.2 Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Application (2016-2026)

9.3 Asia-Pacific Hepatitis B Human Immunoglobulin Market Size by Region

9.3.1 Asia-Pacific Hepatitis B Human Immunoglobulin Sales in Volume by Region (2016-2026)

9.3.2 Asia-Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2026)

9.3.3 China Market Size and Forecast (2016-2026)

9.3.4 Japan Market Size and Forecast (2016-2026)

9.3.5 Korea Market Size and Forecast (2016-2026)

9.3.6 India Market Size and Forecast (2016-2026)

9.3.7 Southeast Asia Market Size and Forecast (2016-2026)

9.3.8 Australia Market Size and Forecast (2016-2026)

10 South America by Country, by Type, and by Application

10.1 South America Hepatitis B Human Immunoglobulin Sales by Type (2016-2026)

10.2 South America Hepatitis B Human Immunoglobulin Sales by Application (2016-2026)

10.3 South America Hepatitis B Human Immunoglobulin Market Size by Country

10.3.1 South America Hepatitis B Human Immunoglobulin Sales in Volume by Country (2016-2026)

10.3.2 South America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2026)

10.3.3 Brazil Market Size and Forecast (2016-2026)

10.3.4 Argentina Market Size and Forecast (2016-2026)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Type (2016-2026)

11.2 Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Application (2016-2026)

11.3 Middle East & Africa Hepatitis B Human Immunoglobulin Market Size by Country

11.3.1 Middle East & Africa Hepatitis B Human Immunoglobulin Sales in Volume by Country (2016-2026)

11.3.2 Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2026)

11.3.3 Turkey Market Size and Forecast (2016-2026)

11.3.4 Egypt Market Size and Forecast (2016-2026)

11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)

11.3.6 South Africa Market Size and Forecast (2016-2026)

12 Sales Channel, Distributors, Traders and Dealers

12.1 Sales Channel

12.1.1 Direct Marketing

12.1.2 Indirect Marketing

12.2 Hepatitis B Human Immunoglobulin Typical Distributors

12.3 Hepatitis B Human Immunoglobulin Typical Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Research Process and Data Source

14.3 Disclaimer

List of Tables

Table 1. Global Hepatitis B Human Immunoglobulin Revenue by Type, (USD Million), 2021-2026

Table 2. Global Hepatitis B Human Immunoglobulin Revenue by Application, (USD Million), 2021-2026

Table 3. Biotest Basic Information, Manufacturing Base and Competitors

Table 4. Biotest Major Business

Table 5. Biotest Hepatitis B Human Immunoglobulin Product and Services

Table 6. Biotest Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 7. ADMA Biologics Basic Information, Manufacturing Base and Competitors

Table 8. ADMA Biologics Major Business

Table 9. ADMA Biologics Hepatitis B Human Immunoglobulin Product and Services

Table 10. ADMA Biologics Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 11. Sanquin Blood Basic Information, Manufacturing Base and Competitors

Table 12. Sanquin Blood Major Business

Table 13. Sanquin Blood Hepatitis B Human Immunoglobulin Product and Services

Table 14. Sanquin Blood Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 15. Bio Products Laboratory Basic Information, Manufacturing Base and Competitors

Table 16. Bio Products Laboratory Major Business

Table 17. Bio Products Laboratory Hepatitis B Human Immunoglobulin Product and Services

Table 18. Bio Products Laboratory Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 19. Baxter Basic Information, Manufacturing Base and Competitors

Table 20. Baxter Major Business

Table 21. Baxter Hepatitis B Human Immunoglobulin Product and Services

Table 22. Baxter Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 23. CSL Basic Information, Manufacturing Base and Competitors

Table 24. CSL Major Business

Table 25. CSL Hepatitis B Human Immunoglobulin Product and Services

Table 26. CSL Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 27. Bayer Basic Information, Manufacturing Base and Competitors

Table 28. Bayer Major Business

Table 29. Bayer Hepatitis B Human Immunoglobulin Product and Services

Table 30. Bayer Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 31. Grifols Basic Information, Manufacturing Base and Competitors

Table 32. Grifols Major Business

Table 33. Grifols Hepatitis B Human Immunoglobulin Product and Services

Table 34. Grifols Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 35. Octapharma Basic Information, Manufacturing Base and Competitors

Table 36. Octapharma Major Business

Table 37. Octapharma Hepatitis B Human Immunoglobulin Product and Services

Table 38. Octapharma Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 39. Hualan Biological Basic Information, Manufacturing Base and Competitors

Table 40. Hualan Biological Major Business

Table 41. Hualan Biological Hepatitis B Human Immunoglobulin Product and Services

Table 42. Hualan Biological Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 43. China Biologic Basic Information, Manufacturing Base and Competitors

Table 44. China Biologic Major Business

Table 45. China Biologic Hepatitis B Human Immunoglobulin Product and Services

Table 46. China Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 47. Tiantan Biologic Basic Information, Manufacturing Base and Competitors

Table 48. Tiantan Biologic Major Business

Table 49. Tiantan Biologic Hepatitis B Human Immunoglobulin Product and Services

Table 50. Tiantan Biologic Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 51. Shuanglin Bio-pharmacy Basic Information, Manufacturing Base and Competitors

Table 52. Shuanglin Bio-pharmacy Major Business

Table 53. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Product and Services

Table 54. Shuanglin Bio-pharmacy Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 55. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors

Table 56. Sichuan Yuanda Shuyang Major Business

Table 57. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Product and Services

Table 58. Sichuan Yuanda Shuyang Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 59. Shanghai Institute of Biological Basic Information, Manufacturing Base and Competitors

Table 60. Shanghai Institute of Biological Major Business

Table 61. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Product and Services

Table 62. Shanghai Institute of Biological Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 63. Hualan Basic Information, Manufacturing Base and Competitors

Table 64. Hualan Major Business

Table 65. Hualan Hepatitis B Human Immunoglobulin Product and Services

Table 66. Hualan Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 67. Shanghai RAAS Blood Products Basic Information, Manufacturing Base and Competitors

Table 68. Shanghai RAAS Blood Products Major Business

Table 69. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Product and Services

Table 70. Shanghai RAAS Blood Products Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 71. China Grand Enterprises Basic Information, Manufacturing Base and Competitors

Table 72. China Grand Enterprises Major Business

Table 73. China Grand Enterprises Hepatitis B Human Immunoglobulin Product and Services

Table 74. China Grand Enterprises Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 75. Nanyue Biopharmaceutical Basic Information, Manufacturing Base and Competitors

Table 76. Nanyue Biopharmaceutical Major Business

Table 77. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 78. Nanyue Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 79. Boya Biopharmaceutical Group Basic Information, Manufacturing Base and Competitors

Table 80. Boya Biopharmaceutical Group Major Business

Table 81. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Product and Services

Table 82. Boya Biopharmaceutical Group Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 83. Tonglu Biopharmaceutical Basic Information, Manufacturing Base and Competitors

Table 84. Tonglu Biopharmaceutical Major Business

Table 85. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 86. Tonglu Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 87. Shandong Taibang Biopharmaceutical Basic Information, Manufacturing Base and Competitors

Table 88. Shandong Taibang Biopharmaceutical Major Business

Table 89. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 90. Shandong Taibang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 91. Guangdong Shuanglin Biopharmaceutical Basic Information, Manufacturing Base and Competitors

Table 92. Guangdong Shuanglin Biopharmaceutical Major Business

Table 93. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 94. Guangdong Shuanglin Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 95. Chengdu Rongsheng Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 96. Chengdu Rongsheng Pharmaceutical Major Business

Table 97. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 98. Chengdu Rongsheng Pharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 99. Shenzhen Weiguang Biopharmaceutical Basic Information, Manufacturing Base and Competitors

Table 100. Shenzhen Weiguang Biopharmaceutical Major Business

Table 101. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Product and Services

Table 102. Shenzhen Weiguang Biopharmaceutical Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 103. Green Cross (China) Biological Products Basic Information, Manufacturing Base and Competitors

Table 104. Green Cross (China) Biological Products Major Business

Table 105. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Product and Services

Table 106. Green Cross (China) Biological Products Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 107. Sinopharm Basic Information, Manufacturing Base and Competitors

Table 108. Sinopharm Major Business

Table 109. Sinopharm Hepatitis B Human Immunoglobulin Product and Services

Table 110. Sinopharm Hepatitis B Human Immunoglobulin Sales (Litre), Price (US$/ML), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)

Table 111. Global Hepatitis B Human Immunoglobulin Sales by Manufacturer (2019-2021e) & (Litre)

Table 112. Global Hepatitis B Human Immunoglobulin Revenue by Manufacturer (2019-2021e) & (USD Million)

Table 113. Market Position of Manufacturers in Hepatitis B Human Immunoglobulin, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020

Table 114. Global Hepatitis B Human Immunoglobulin Production Capacity by Company, (Litre): 2020 VS 2021

Table 115. Head Office and Hepatitis B Human Immunoglobulin Production Site of Key Manufacturer

Table 116. Hepatitis B Human Immunoglobulin New Entrant and Capacity Expansion Plans

Table 117. Hepatitis B Human Immunoglobulin Mergers & Acquisitions in the Past Five Years

Table 118. Global Hepatitis B Human Immunoglobulin Sales by Region (2016-2021e) & (Litre)

Table 119. Global Hepatitis B Human Immunoglobulin Sales by Region (2021-2026) & (Litre)

Table 120. Global Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)

Table 121. Global Hepatitis B Human Immunoglobulin Revenue by Region (2021-2026) & (USD Million)

Table 122. Global Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 123. Global Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 124. Global Hepatitis B Human Immunoglobulin Revenue by Type (2016-2021e) & (USD Million)

Table 125. Global Hepatitis B Human Immunoglobulin Revenue by Type (2021-2026) & (USD Million)

Table 126. Global Hepatitis B Human Immunoglobulin Price by Type (2016-2021e) & (US$/ML)

Table 127. Global Hepatitis B Human Immunoglobulin Price by Type (2021-2026) & (US$/ML)

Table 128. Global Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 129. Global Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 130. Global Hepatitis B Human Immunoglobulin Revenue by Application (2016-2021e) & (USD Million)

Table 131. Global Hepatitis B Human Immunoglobulin Revenue by Application (2021-2026) & (USD Million)

Table 132. Global Hepatitis B Human Immunoglobulin Price by Application (2016-2021e) & (US$/ML)

Table 133. Global Hepatitis B Human Immunoglobulin Price by Application (2021-2026) & (US$/ML)

Table 134. North America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021e) & (Litre)

Table 135. North America Hepatitis B Human Immunoglobulin Sales by Country (2021-2026) & (Litre)

Table 136. North America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)

Table 137. North America Hepatitis B Human Immunoglobulin Revenue by Country (2021-2026) & (USD Million)

Table 138. North America Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 139. North America Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 140. North America Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 141. North America Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 142. Europe Hepatitis B Human Immunoglobulin Sales by Country (2016-2021e) & (Litre)

Table 143. Europe Hepatitis B Human Immunoglobulin Sales by Country (2021-2026) & (Litre)

Table 144. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)

Table 145. Europe Hepatitis B Human Immunoglobulin Revenue by Country (2021-2026) & (USD Million)

Table 146. Europe Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 147. Europe Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 148. Europe Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 149. Europe Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 150. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Region (2016-2021e) & (Litre)

Table 151. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Region (2021-2026) & (Litre)

Table 152. Asia-Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2016-2021e) & (USD Million)

Table 153. Asia-Pacific Hepatitis B Human Immunoglobulin Revenue by Region (2021-2026) & (USD Million)

Table 154. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 155. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 156. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 157. Asia-Pacific Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 158. South America Hepatitis B Human Immunoglobulin Sales by Country (2016-2021e) & (Litre)

Table 159. South America Hepatitis B Human Immunoglobulin Sales by Country (2021-2026) & (Litre)

Table 160. South America Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)

Table 161. South America Hepatitis B Human Immunoglobulin Revenue by Country (2021-2026) & (USD Million)

Table 162. South America Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 163. South America Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 164. South America Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 165. South America Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 166. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Country (2016-2021e) & (Litre)

Table 167. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Country (2021-2026) & (Litre)

Table 168. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country (2016-2021e) & (USD Million)

Table 169. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue by Country (2021-2026) & (USD Million)

Table 170. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Type (2016-2021e) & (Litre)

Table 171. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Type (2021-2026) & (Litre)

Table 172. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Application (2016-2021e) & (Litre)

Table 173. Middle East & Africa Hepatitis B Human Immunoglobulin Sales by Application (2021-2026) & (Litre)

Table 174. Direct Channel Pros & Cons

Table 175. Indirect Channel Pros & Cons

Table 176. Hepatitis B Human Immunoglobulin Typical Distributors

Table 177. Hepatitis B Human Immunoglobulin Typical Customers

List of Figures

Figure 1. Hepatitis B Human Immunoglobulin Picture

Figure 2. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type in 2020

Figure 3. 100IU

Figure 4. 200IU

Figure 5. 400IU

Figure 6. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application in 2020

Figure 7. Measles Prevention

Figure 8. Prevention of Hepatitis B Virus Infection

Figure 9. Hepatitis A Virus Infection

Figure 10. Other

Figure 11. Global Hepatitis B Human Immunoglobulin Market Size, (USD Million) & (Litre): 2020 VS 2021 VS 2026

Figure 12. Global Hepatitis B Human Immunoglobulin Market Size and Forecast (2016-2026) & (USD Million)

Figure 13. Global Hepatitis B Human Immunoglobulin Sales (2016-2026) & (Litre)

Figure 14. Global Hepatitis B Human Immunoglobulin Price by Type (2016-2026) & (US$/ML)

Figure 15. Global Hepatitis B Human Immunoglobulin Production Capacity (2016-2026) & (Litre)

Figure 16. Global Hepatitis B Human Immunoglobulin Production Capacity by Geographic Region: 2020 VS 2021

Figure 17. Hepatitis B Human Immunoglobulin Market Drivers

Figure 18. Hepatitis B Human Immunoglobulin Market Restraints

Figure 19. Hepatitis B Human Immunoglobulin Market Trends

Figure 20. Global Hepatitis B Human Immunoglobulin Sales Market Share by Manufacturer in 2020

Figure 21. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Manufacturer in 2020

Figure 22. Hepatitis B Human Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 23. Top 3 Hepatitis B Human Immunoglobulin Manufacturer (Revenue) Market Share in 2020

Figure 24. Top 6 Hepatitis B Human Immunoglobulin Manufacturer (Revenue) Market Share in 2020

Figure 25. Global Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2026)

Figure 26. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2016-2026)

Figure 27. North America Hepatitis B Human Immunoglobulin Revenue (2016-2026) & (USD Million)

Figure 28. Europe Hepatitis B Human Immunoglobulin Revenue (2016-2026) & (USD Million)

Figure 29. Asia-Pacific Hepatitis B Human Immunoglobulin Revenue (2016-2026) & (USD Million)

Figure 30. South America Hepatitis B Human Immunoglobulin Revenue (2016-2026) & (USD Million)

Figure 31. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue (2016-2026) & (USD Million)

Figure 32. Global Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2026)

Figure 33. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Type (2016-2026)

Figure 34. Global Hepatitis B Human Immunoglobulin Price by Type (2016-2026) & (US$/ML)

Figure 35. Global Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 36. Global Hepatitis B Human Immunoglobulin Revenue Market Share by Application (2016-2026)

Figure 37. Global Hepatitis B Human Immunoglobulin Price by Application (2016-2026) & (US$/ML)

Figure 38. North America Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2026)

Figure 39. North America Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 40. North America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2026)

Figure 41. North America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2026)

Figure 42. United States Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 43. Canada Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 44. Mexico Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 45. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2026)

Figure 46. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 47. Europe Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2026)

Figure 48. Europe Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2026)

Figure 49. Germany Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. France Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. United Kingdom Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 52. Russia Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 53. Italy Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 54. Asia-Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2026)

Figure 55. Asia-Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 56. Asia-Pacific Hepatitis B Human Immunoglobulin Sales Market Share by Region (2016-2026)

Figure 57. Asia-Pacific Hepatitis B Human Immunoglobulin Revenue Market Share by Region (2016-2026)

Figure 58. China Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Japan Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 60. Korea Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 61. India Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. Southeast Asia Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Australia Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South America Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2026)

Figure 65. South America Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 66. South America Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2026)

Figure 67. South America Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2026)

Figure 68. Brazil Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 69. Argentina Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share by Type (2016-2026)

Figure 71. Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share by Application (2016-2026)

Figure 72. Middle East & Africa Hepatitis B Human Immunoglobulin Sales Market Share by Country (2016-2026)

Figure 73. Middle East & Africa Hepatitis B Human Immunoglobulin Revenue Market Share by Country (2016-2026)

Figure 74. Turkey Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. Egypt Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 76. Saudi Arabia Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. South Africa Hepatitis B Human Immunoglobulin Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. Sales Channel: Direct Channel vs Indirect Channel

Figure 79. Methodology

Figure 80. Research Process and Data Source